Across the country, state lawmakers are considering ways to address the risks posed by the explosion of power-hungry data ...
In this week’s Crypto Long & Short Newsletter, Ruchir Gupta writes on how we’re moving toward a true fixed-income market for ...
In patients who had progressed on one prior ARPI, FG3246 plus enzalutamide yielded a median radiographic progression-free ...
Kyntra Bio, Inc. (NASDAQ:KYNB) Q4 2025 Earnings Call Transcript March 16, 2026 Kyntra Bio, Inc. beats earnings expectations. Reported EPS is $-3.61, expectations were $-3.885. Operator: Thank you for ...
Lens AI, powered by the proprietary HIFT system, advanced functional adjacency capabilities and identified a single conserved functional feature across 2,000+ influenza sequences. Dengue Pipeline -- ...
The literature on physician-mediated interventions to reduce costs is scant and provides little guidance on effective ...
Third-party apps, aftermarket parts, and hidden settings can make your Peloton experience so much better.
Dividend Declaration -- The Board declared a $0.42 per share dividend, representing a 9.8% annualized rate on ending book ...
Good afternoon, and welcome to Arthur J. Gallagher & Company's quarterly investor meeting with management. [Operator Instructions] Today's call is being recorded. If you have any objections, you may ...
Q4 2025 Earnings Call March 4, 2026 5:00 PM ESTCompany ParticipantsKyle Pilkington - Chief Legal OfficerQichao Hu - ...
Thank you, Jonathan, and thanks to all of you for joining us this afternoon to review Definitive Healthcare Corp.'s fourth ...
Thank you, Justine, and thank you, everybody, for joining us this morning. As this is our year-end 2025 call, I wanted to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results